Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Compensation Amount
Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Compensation Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessCompensationAmount.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation nondeductible expense excess compensation amount of $473.75K in Q4 2024.
- How has Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation amount changed year-over-year?
- Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation amount decreased by 50.3% year-over-year, from $953.5K to $473.75K.
- What does effective income tax rate reconciliation nondeductible expense excess compensation amount mean?
- The amount of compensation paid that cannot be deducted for tax purposes.
- How do you interpret effective income tax rate reconciliation nondeductible expense excess compensation amount?
- Higher amounts indicate significant non-deductible compensation expenses, which increase the effective tax rate.
- How does effective income tax rate reconciliation nondeductible expense excess compensation amount compare across companies?
- Common in companies with high stock-based compensation packages.